Literature DB >> 16934308

R5- and X4-HIV-1 use differentially the endometrial epithelial cells HEC-1A to ensure their own spread: implication for mechanisms of sexual transmission.

Héla Saïdi1, Giuliana Magri, Nadine Nasreddine, Mary Réquena, Laurent Bélec.   

Abstract

The mechanism of viral transmission across the mucosal barrier is poorly understood. Using the endometrial epithelium-derived cell line HEC-1A, we found that the cells are capable of sequestering large numbers of HIV-1 particles but are refractory to cell-free viral infection. The removal of heparan sulfate moieties of cell-surface proteoglycans (HSPG) from the apical pole of HEC-1A accounted for at least 60% of both R5- and X4-HIV-1 attachment, showing their important implication in viral attachment. HEC-1A cells also have the capacity to endocytose a weak proportion of the attached virus and pass it along to underlying cells. Fucose, N-acetylglucosamine and mannosylated-residues inhibited the transcytosis of some virus isolates, suggesting that mannose receptors can be implicated on the both R5- and X4-HIV-1 transcytosis. The inhibition of HIV transcytosis by blocking CCR5 mAb suggests the implication of specific interaction between the viral gp120 and sulfated moiety of syndecans during the transcytosis of mostly R5- and X4-HIV-1. At the basolateral pole of HEC-1A, HSPG sequestered X4- and not R5-HIV-1, highlighting the important role of HEC-1A as an X4 virus reservoir. The cell-free virus particles that have transcytosed could infect activated T cells but with a weaker efficiency than virus that had not transcytosed. The specific stimulation of HEC-1A by R5-HIV-1 increased the release of monocytes/chemokines-attracting chemokines (IL-8 and GR0) and proinflammatory cytokines (TNF-beta and IL-1alpha) that enhanced the production of virus by activated T cells. This study suggests that R5 and X4 viruses can differentially use epithelial cells to ensure their own spread.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16934308     DOI: 10.1016/j.virol.2006.07.029

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  37 in total

1.  Epstein-Barr virus transcytosis through polarized oral epithelial cells.

Authors:  Sharof M Tugizov; Rossana Herrera; Joel M Palefsky
Journal:  J Virol       Date:  2013-05-22       Impact factor: 5.103

Review 2.  Innate and adaptive anti-HIV immune responses in the female reproductive tract.

Authors:  Marta Rodriguez-Garcia; Mickey V Patel; Charles R Wira
Journal:  J Reprod Immunol       Date:  2013-03       Impact factor: 4.054

Review 3.  Immune responses to HIV in the female reproductive tract, immunologic parallels with the gastrointestinal tract, and research implications.

Authors:  Barbara L Shacklett; Ruth M Greenblatt
Journal:  Am J Reprod Immunol       Date:  2011-01-12       Impact factor: 3.886

Review 4.  Potential mechanisms for increased HIV-1 transmission across the endocervical epithelium during C. trachomatis infection.

Authors:  Danny J Schust; Joyce A Ibana; Lyndsey R Buckner; Mercedes Ficarra; Jun Sugimoto; Angela M Amedee; Alison J Quayle
Journal:  Curr HIV Res       Date:  2012-04       Impact factor: 1.581

5.  HIV is inactivated after transepithelial migration via adult oral epithelial cells but not fetal epithelial cells.

Authors:  Sharof M Tugizov; Rossana Herrera; Piri Veluppillai; Deborah Greenspan; Vanessa Soros; Warner C Greene; Jay A Levy; Joel M Palefsky
Journal:  Virology       Date:  2010-11-05       Impact factor: 3.616

6.  Anti-HIV-1 activity of elafin is more potent than its precursor's, trappin-2, in genital epithelial cells.

Authors:  Anna G Drannik; Kakon Nag; Xiao-Dan Yao; Bethany M Henrick; Sumiti Jain; T Blake Ball; Francis A Plummer; Charles Wachihi; Joshua Kimani; Kenneth L Rosenthal
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

7.  Differential transmission of HIV traversing fetal oral/intestinal epithelia and adult oral epithelia.

Authors:  Sharof M Tugizov; Rossana Herrera; Piri Veluppillai; Deborah Greenspan; Vanessa Soros; Warner C Greene; Jay A Levy; Joel M Palefsky
Journal:  J Virol       Date:  2011-12-28       Impact factor: 5.103

Review 8.  Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection.

Authors:  Zdenek Hel; Elizabeth Stringer; Jiri Mestecky
Journal:  Endocr Rev       Date:  2009-11-10       Impact factor: 19.871

9.  Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies.

Authors:  Mimi Ghosh; John V Fahey; Zheng Shen; Timothy Lahey; Susan Cu-Uvin; Zhijin Wu; Kenneth Mayer; Peter F Wright; John C Kappes; Christina Ochsenbauer; Charles R Wira
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

10.  Differential activity of candidate microbicides against early steps of HIV-1 infection upon complement virus opsonization.

Authors:  Mohammad-Ali Jenabian; Héla Saïdi; Charlotte Charpentier; Hicham Bouhlal; Dominique Schols; Jan Balzarini; Thomas W Bell; Guido Vanham; Laurent Bélec
Journal:  AIDS Res Ther       Date:  2010-06-14       Impact factor: 2.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.